ADC Biotechnology has secured £1.14 million in funding from investment managers, Downing LLP to advance the company’s business efforts for faster market penetration in the U.S. The investment will also assist the development of an advanced bioconjugation method, a new ADC manufacturing approach, and a conceptual design for implementation of a fill-finish operation at the company’s facility in Deeside.   ADC Bio is in the process of developing and internally validating its new upstream bioconju...